Schulman S - Search Results

1

Continuous infusion of B-domain deleted recombinant factor VIII (ReFacto) in patients with haemophilia A undergoing surgery: clinical experience.

Stieltjes N, Altisent C, Auerswald G, Négrier C, Pouzol P, Reynaud J, Roussel-Robert V, Savidge GF, Villar A, Schulman S. Stieltjes N, et al. Among authors: schulman s. Haemophilia. 2004 Sep;10(5):452-8. doi: 10.1111/j.1365-2516.2004.01013.x. Haemophilia. 2004. PMID: 15357770

2

Continuous intravenous infusion of a plasma-derived factor IX concentrate (Mononine) in haemophilia B.

Hoots WK, Leissinger C, Stabler S, Schwartz BA, White G, Dasani H, Massion C, Negrier C, Schindel F, Schulman S. Hoots WK, et al. Among authors: schulman s. Haemophilia. 2003 Mar;9(2):164-72. doi: 10.1046/j.1365-2516.2003.00721.x. Haemophilia. 2003. PMID: 12614367 Clinical Trial.

3

Continuous infusion.

Schulman S. Schulman S. Haemophilia. 2003 Jul;9(4):368-75. doi: 10.1046/j.1365-2516.2003.00765.x. Haemophilia. 2003. PMID: 12828670 Review.

4

Experiences with continuous infusion of recombinant activated factor VII.

Schulman S, d'Oiron R, Martinowitz U, Pasi J, Briquel ME, Mauser-Bunschoten E, Morfini M, Ritchie B, Goudemand J, Lloyd J, McPherson J, Négrier C, Peerlinck K, Petrini P, Tusell J. Schulman S, et al. Blood Coagul Fibrinolysis. 1998 Mar;9 Suppl 1:S97-101. Blood Coagul Fibrinolysis. 1998. PMID: 9819037 Clinical Trial.

5

Efficacy of a high purity, chemically treated and nanofiltered factor IX concentrate for continuous infusion in haemophilia patients undergoing surgery.

Schulman S, Wallensten R, White B, Smith OP. Schulman S, et al. Haemophilia. 1999 Mar;5(2):96-100. doi: 10.1046/j.1365-2516.1999.00284.x. Haemophilia. 1999. PMID: 10215956

6

Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene.

Herrmann FH, Wulff K, Auerswald G, Schulman S, Astermark J, Batorova A, Kreuz W, Pollmann H, Ruiz-Saez A, De Bosch N, Salazar-Sanchez L; Greifswald Factor FVII Deficiency Study Group. Herrmann FH, et al. Among authors: schulman s. Haemophilia. 2009 Jan;15(1):267-80. doi: 10.1111/j.1365-2516.2008.01910.x. Epub 2008 Oct 30. Haemophilia. 2009. PMID: 18976247

7

Safety, efficacy and lessons from continuous infusion with rFVIIa. rFVIIa-CI Group.

Schulman S. Schulman S. Haemophilia. 1998 Jul;4(4):564-7. doi: 10.1046/j.1365-2516.1998.440564.x. Haemophilia. 1998. PMID: 9873795 Review.

8

Minimizing factor requirements for surgery without increased risk.

Schulman S, Loogna J, Wallensten R. Schulman S, et al. Haemophilia. 2004 Oct;10 Suppl 4:35-40. doi: 10.1111/j.1365-2516.2004.01041.x. Haemophilia. 2004. PMID: 15479370

9

On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome.

Steen Carlsson K, Höjgård S, Glomstein A, Lethagen S, Schulman S, Tengborn L, Lindgren A, Berntorp E, Lindgren B. Steen Carlsson K, et al. Among authors: schulman s. Haemophilia. 2003 Sep;9(5):555-66. doi: 10.1046/j.1365-2516.2003.00817.x. Haemophilia. 2003. PMID: 14511294 Free article.

10

Home therapy with continuous infusion of factor VIII after minor surgery or serious haemorrhage.

Varon D, Schulman S, Bashari D, Martinowitz U. Varon D, et al. Among authors: schulman s. Haemophilia. 1996 Oct;2(4):207-10. doi: 10.1111/j.1365-2516.1996.tb00138.x. Haemophilia. 1996. PMID: 27214358

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

939 results

Search Page